1. World Health Organization. The Importance of Pharmacovigilance: Safety Monitoring of medicinal products. World Health Organization; 2002. Available at:
http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf
.
2. Uppsala Monitoring Centre. Members of the WHO Programme for International Drug Monitoring [cited 27 Feb 2018]. Available at:
https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members/
.
3. Uppsala Monitoring Centre. Vigilyze Statistics for Africa. 2017 [cited 2 Oct 2017]. Available at:
https://vigilyze.who-umc.org/#/
.
4. Olsson S. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf. 1998;19(1):1–10.
5. The Uganda Gazette. The National Drug Policy and Authority (Pharmacovigilance) Regulations, 2014. Pub.L. No. 37 Uganda; 2014; pp. 1263–72. Available at:
http://www.nda.or.ug/files/downloads/PharmacovigilanceRegulation.pdf
.